Stefania D’Atri

7.4k citations

118 papers · 5.9k · 1 hit paper · h-index 34

Impact in

Oncology top 1%
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Cancer Research top 2%
- Cancer Genomics and Diagnostics

Papers in

Immunology 26
- Immune Cell Function and Interaction 12
- Immunotherapy and Immune Responses 8
Molecular Biology 65
- Angiogenesis and VEGF in Cancer 17
- DNA Repair Mechanisms 15
- Melanoma and MAPK Pathways 12

Co-authors: Pedro Miguel Lacal (36 shared papers)Enzo Bonmassar (44 shared papers)Grazia Graziani (33 shared papers)Elena Pagani (18 shared papers)Federica Ruffini (18 shared papers)Lucio Tentori (23 shared papers)Giovanna Zambruno (11 shared papers)Josef Jiricny (11 shared papers)
Journals: International Journal of Oncology (7 papers)Oncotarget (5 papers)Pharmacological Research (4 papers)Journal of Experimental & Clinical Cancer Research (4 papers)Genes Chromosomes and Cancer (4 papers)
Partner nations: Italy United States Switzerland

In The Last Decade

Stefania D’Atri

114 papers receiving 5.8k citations

Stefania D’Atri's Hit Papers

align trajectories log scale

Genomic Classification of Cutaneous Melanoma 2015 · 2.5k citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2015 Cell

Peers

Countries citing papers authored by Stefania D’Atri

Since Specialization

Citations

This map shows the geographic impact of Stefania D’Atri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania D’Atri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania D’Atri more than expected).

Fields of papers citing papers by Stefania D’Atri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania D’Atri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania D’Atri. The network helps show where Stefania D’Atri may publish in the future.

Co-authors

The 25 scholars most cited alongside Stefania D’Atri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stefania D’Atri Line = papers co-authored together Stefania D’Atri links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Genomic Classification of Cutaneous Melanoma Cell ·Rehan Akbani, Kadir Caner Akdemir, Bülent Arman Aksoy, Monique Albert, Adrian Ally, Samirkumar B. Amin, Harindra Arachchi, Arshi Arora Hit paper breakdown →	2015	2509
2	Involvement of the Mismatch Repair System in Temozolomide-Induced Apoptosis Molecular Pharmacology ·Stefania D’Atri, Lucio Tentori, Pedro Miguel Lacal, Grazia Graziani, Elena Pagani, Elena Benincasa, Giovanna Zambruno, Enzo Bonmassar	1998	238
3	Downregulation of 14-3-3σ Prevents Clonal Evolution and Leads to Immortalization of Primary Human Keratinocytes The Journal of Cell Biology ·Elena Dellambra, Osvaldo Golisano, Sergio Bondanza, Emanuela Siviero, Pedro Miguel Lacal, Marta Molinari, Stefania D’Atri, Michele De Luca	2000	204
4	Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells. PubMed ·Aristide Floridi, Paggi Mg, Stefania D’Atri, De Martino C, Marcante Ml, Bruno Silvestrini, Annalisa Caputo	1981	182
5	Human Melanoma Cells Secrete and Respond to Placenta Growth Factor and Vascular Endothelial Growth Factor Journal of Investigative Dermatology ·Pedro Miguel Lacal, Cristina Maria Failla, Elena Pagani, Teresa Odorisio, Cataldo Schietroma, Sabrina Falcinelli, Giovanna Zambruno, Stefania D’Atri	2000	155
6	Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules Journal of Experimental & Clinical Cancer Research ·Zaira Boussadia, Jessica Lamberti, Fabrizio Mattei, Elisabetta Pizzi, Rossella Puglisi, Cristiana Zanetti, Luca Pasquini, Federica Fratini	2018	134
7	DNA Damage Induced by Temozolomide Signals to both ATM and ATR: Role of the Mismatch Repair System Molecular Pharmacology ·Simona Caporali, Sabrina Falcinelli, Giuseppe Starace, Maria Teresa Russo, Enzo Bonmassar, Josef Jiricny, Stefania D’Atri	2004	107
8	Immunization of Stage IV Melanoma Patients with Melan-A/MART-1 and gp100 Peptides plus IFN-α Results in the Activation of Specific CD8+ T Cells and Monocyte/Dendritic Cell Precursors Cancer Research ·Tiziana Di Pucchio, Lorenzo Pilla, Imerio Capone, Maria Ferrantini, Enrica Montefiore, Francesca Urbani, Roberto Patuzzo, Elisabetta Pennacchioli	2006	104
9	MicroRNA‐155 targets theSKIgene in human melanoma cell lines Pigment Cell & Melanoma Research ·Lauretta Levati, Elena Pagani, Sveva Romani, Daniele Castiglia, Eugenia Piccinni, Claudia Covaciu, Patrizia Caporaso, Sergio Bondanza	2011	78
10	Vascular endothelial growth factor‐C expression correlates with lymph node localization of human melanoma metastases Cancer ·Cataldo Schietroma, Francesca Cianfarani, Pedro Miguel Lacal, Teresa Odorisio, Angela Orecchia, Jean Kanitakis, Stefania D’Atri, Cristina Maria Failla	2003	74
11	The Effect of O6-Alkylguanine-DNA Alkyltransferase and Mismatch Repair Activities on the Sensitivity of Human Melanoma Cells to Temozolomide, 1,3-bis(2-Chloroethyl)1-nitrosourea, and Cisplatin Journal of Pharmacology and Experimental Therapeutics ·Rita Pepponi, Giancarlo Marra, Maria Pia Fuggetta, Sabrina Falcinelli, Elena Pagani, Enzo Bonmassar, Josef Jiricny, Stefania D’Atri	2003	73
12	miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A Journal of Experimental & Clinical Cancer Research ·Simona Caporali, Adriana Agnese Amaro, Lauretta Levati, Ester Alvino, Pedro Miguel Lacal, Simona Mastroeni, Federica Ruffini, Laura Bonmassar	2019	73
13	AKT Is Activated in an Ataxia-Telangiectasia and Rad3-Related-Dependent Manner in Response to Temozolomide and Confers Protection against Drug-Induced Cell Growth Inhibition Molecular Pharmacology ·Simona Caporali, Lauretta Levati, Giuseppe Starace, Gianluca Ragone, Enzo Bonmassar, Ester Alvino, Stefania D’Atri	2008	65
14	An autocrine loop directed by the vascular endothelial growth factor promotes invasiveness of human melanoma cells International Journal of Oncology ·Pedro Miguel Lacal, Federica Ruffini, Elena Pagani, Stefania D’Atri	2005	61
15	Cilengitide downmodulates invasiveness and vasculogenic mimicry of neuropilin 1 expressing melanoma cells through the inhibition of αvβ5 integrin International Journal of Cancer ·Federica Ruffini, Grazia Graziani, Lauretta Levati, Lucio Tentori, Stefania D’Atri, Pedro Miguel Lacal	2014	57
16	Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor International Journal of Oncology ·Simona Caporali, Ester Alvino, Pedro Miguel Lacal, Lauretta Levati, Giorgio Giurato, Domenico Memoli, Elisabetta Caprini, Gian Carlo Antonini Cappellini	2016	56
17	Inhibition of O6-Alkylguanine DNA-Alkyltransferase or Poly(ADP-ribose) Polymerase Increases Susceptibility of Leukemic Cells to Apoptosis Induced by Temozolomide Molecular Pharmacology ·Lucio Tentori, Laura Orlando, Pedro Miguel Lacal, Elena Benincasa, Isabella Faraoni, Enzo Bonmassar, Stefania D’Atri, Grazia Graziani	1997	53
18	Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy Oncogene ·Ji‐Chun Yang, Jason Luke Parsons, Nils Henrik Nicolay, Simona Caporali, Chris F. Harrington, Rajinder Singh, David E. Finch, Stefania D’Atri	2009	53
19	Attenuation of O6-Methylguanine-DNA Methyltransferase Activity and mRNA Levels by Cisplatin and Temozolomide in Jurkat Cells Journal of Pharmacology and Experimental Therapeutics ·Stefania D’Atri, Grazia Graziani, Pedro Miguel Lacal, V. Nistico, Sara Gilberti, Isabella Faraoni, Amanda J. Watson, Enzo Bonmassar	2000	51
20	Chemosensitivity to triazene compounds and O6-alkylguanine-DNA alkyltransferase levels: Studies with blasts of leukaemic patients Annals of Oncology ·Stefania D’Atri, Daniela Piccioni, Aurora Castellano, V. Tuorto, Annibale Franchi, Kening Lu, Neal P. Christiansen, Stanley Frankel	1995	48

About Stefania D’Atri

Stefania D’Atri is a scholar working on Immunology, Molecular Biology, Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 118 papers that have together received 5.9k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (17 papers), DNA Repair Mechanisms (15 papers), Genetic factors in colorectal cancer (13 papers), Immune Cell Function and Interaction (12 papers), Melanoma and MAPK Pathways (12 papers), Immunotherapy and Immune Responses (8 papers), Chemical Reactions and Isotopes (7 papers) and Lymphatic System and Diseases (6 papers). The work is most often cited by research in Oncology (2.4k citations), Cancer Research (1.1k citations), Molecular Biology (3.6k citations), Immunology (1.0k citations) and Genetics (371 citations). Stefania D’Atri has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Pedro Miguel Lacal, Enzo Bonmassar, Grazia Graziani, Elena Pagani, Federica Ruffini, Lucio Tentori, Giovanna Zambruno, Josef Jiricny, Simona Caporali and Lauretta Levati. Their work appears in journals such as International Journal of Oncology, Oncotarget, Pharmacological Research, Journal of Experimental & Clinical Cancer Research and Genes Chromosomes and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Stefania D’Atri

Impact in

Papers in i

In The Last Decade

Stefania D’Atri

Stefania D’Atri's Hit Papers

Peers

Countries citing papers authored by Stefania D’Atri

Fields of papers citing papers by Stefania D’Atri

All Works

About Stefania D’Atri

Explore authors with similar magnitude of impact

Papers in